Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 876

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 9C
Chunk 876
---
 Common Stock under Keystone ELOC, net of issuance costs of $130,321 
     -  
     -  
     -  
     -  
     -  
     -  
     453,500  
     46  
     4,809,657  
     (716,694) 
     -  
     4,093,009 
  
    Issuance
    of shares of Common Stock upon conversion of Series A Preferred Stock 
     (10,073) 
     (8,760,824) 
     -  
     -  
     -  
     -  
     1,723,880  
     172  
     8,760,652  
     -  
     -  
     - 
  
    Issuance
    of shares of Common Stock upon conversion of Series B Preferred Stock 
     -  
     -  
     (353) 
     (281,949) 
     -  
     -  
     53,815  
     5  
     281,944  
     -  
     -  
     - 
  
    Issuance
of shares of Series C Preferred Stock sold to investors, net of issuance costs of $446,438 
     -  
     -  
     -  
     -  
     2,853  
     1,249,999  
     -  
     -  
     (446,438) 
     -  
     -  
     803,561 
  
    Subscription
    receivable for share issued in advance 
     -  
     -  
     -  
     -  
     -  
     -  
     17,270  
     2  
     86,348  
     (86,350) 
     -  
     - 
  
    Deemed dividend – common stock liability, 13,835 shares 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (85,500)